Literature DB >> 16586366

Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts.

Bouke C de Jong1, Philip C Hill, Roger H Brookes, Sebastien Gagneux, David J Jeffries, Jacob K Otu, Simon A Donkor, Annette Fox, Keith P W J McAdam, Peter M Small, Richard A Adegbola.   

Abstract

BACKGROUND: Mycobacterium africanum, a member of the M. tuberculosis complex that is infrequently found outside of western Africa, is the cause of up to half of the tuberculosis cases there.
METHODS: We genotyped mycobacterial isolates obtained from a study of patients with tuberculosis and their household contacts and compared T cell responses and tuberculin skin test results by infecting genotype.
RESULTS: The T cell response to early secreted antigenic target, 6 kDa (ESAT-6), was attenuated in patients with tuberculosis (odds ratio [OR], 0.41 [95% confidence interval {CI}, 0.19-0.89]; P = .024) and household contacts (OR, 0.56 [95% CI, 0.38-0.83]; P = .004) infected with M. africanum, compared with the response in those infected with M. tuberculosis. In these same groups, responses to culture filtrate protein, 10 kDa (CFP-10), were nonsignificantly attenuated (P = .22 and P = .16, respectively), as were tuberculin skin test results (P = .30 and P = .46, respectively). Sequencing of region of difference 1 of M. africanum revealed that Rv3879c is a pseudogene in M. africanum; however, this finding does not provide an obvious mechanism for the attenuated ESAT-6 response.
CONCLUSIONS: This is the first evidence, to our knowledge, that strain differences affect interferon- gamma -based T cell responses. Our findings highlight the need to test new diagnostic candidates against different strains of mycobacteria. Integrating additional immunologic and genomic comparisons of M. tuberculosis and M. africanum into further studies may provide fundamental insights into the interactions between humans and mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16586366     DOI: 10.1086/502977

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  37 in total

Review 1.  Diversity and evolution of Mycobacterium tuberculosis: moving to whole-genome-based approaches.

Authors:  Stefan Niemann; Philip Supply
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-04       Impact factor: 6.915

2.  Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?

Authors:  D I Ling; M Pai; V Davids; L Brunet; L Lenders; R Meldau; G Calligaro; B Allwood; R van Zyl-Smit; J Peter; E Bateman; R Dawson; K Dheda
Journal:  Eur Respir J       Date:  2011-02-24       Impact factor: 16.671

3.  Production of TNF-alpha, IL-12(p40) and IL-17 can discriminate between active TB disease and latent infection in a West African cohort.

Authors:  Jayne S Sutherland; Bouke C de Jong; David J Jeffries; Ifedayo M Adetifa; Martin O C Ota
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

Review 4.  Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa.

Authors:  Bouke C de Jong; Martin Antonio; Sebastien Gagneux
Journal:  PLoS Negl Trop Dis       Date:  2010-09-28

5.  Distinct genotypic profiles of the two major clades of Mycobacterium africanum.

Authors:  Sidra E Gonçalves Vasconcellos; Richard C Huard; Stefan Niemann; Kristin Kremer; Adalberto R Santos; Philip N Suffys; John L Ho
Journal:  BMC Infect Dis       Date:  2010-03-29       Impact factor: 3.090

6.  Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia.

Authors:  Bouke C de Jong; Philip C Hill; Alex Aiken; Timothy Awine; Martin Antonio; Ifedayo M Adetifa; Dolly J Jackson-Sillah; Annette Fox; Kathryn Deriemer; Sebastien Gagneux; Martien W Borgdorff; Keith P W J McAdam; Tumani Corrah; Peter M Small; Richard A Adegbola
Journal:  J Infect Dis       Date:  2008-10-01       Impact factor: 5.226

7.  Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis.

Authors:  Manzour Hernando Hazbón; Alifiya S Motiwala; Magali Cavatore; Michael Brimacombe; Thomas S Whittam; David Alland
Journal:  Antimicrob Agents Chemother       Date:  2008-06-30       Impact factor: 5.191

Review 8.  The past and future of tuberculosis research.

Authors:  Iñaki Comas; Sebastien Gagneux
Journal:  PLoS Pathog       Date:  2009-10-26       Impact factor: 6.823

9.  Immunogenicity of antigens from the TbD1 region present in M. africanum and missing from "modern" M. tuberculosis: a cross- sectional study.

Authors:  Bouke C de Jong; Abdulrahman Hammond; Jacob K Otu; Martin Antonio; Richard A Adegbola; Martin O Ota
Journal:  BMC Infect Dis       Date:  2010-01-19       Impact factor: 3.090

10.  Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies.

Authors:  Iñaki Comas; Susanne Homolka; Stefan Niemann; Sebastien Gagneux
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.